Tag: Migraine

ACP recommends adding triptan to NSAID or acetaminophen to treat moderate-to-severe acute episodic migraine

Significant reduction seen in median headache days per month in both intractable and nonintractable migraine groups

Three recommendations suggest monotherapy options for preventing episodic migraine headache in outpatient settings

Compared with White children, Black and Hispanic children also received less testing, including brain MRI

Symbravo can rapidly eliminate migraine pain within two hours, with efficacy sustained through 24 and 48 hours, across migraine pain severity

Protective effect more pronounced for ischemic stroke and in women with migraine without aura

Reductions in weekly migraine days seen at weeks 1 to 4 and in monthly migraine days in first four weeks

Findings particularly pronounced for those experiencing pandemic-related stressors

Device becomes the first and only remote electrical neuromodulation wearable for migraine treatment for children 8 years and older

Guidelines include 52 recommendations on evaluation, pharmacotherapy, invasive interventions, and nonpharmacologic interventions